Ad
CNCE Short Information Concert Pharmaceuticals Inc.
home / stock / cnce / cnce short
Short Information | Concert Pharmaceuticals Inc. (NASDAQ:CNCE)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 6,059,622 |
| Total Actual Volume | 40,299,282 |
| Short Trends | |
|---|---|
| Cover Days | 19 |
| Short Days | 0 |
| No Change Days | 1 |
| Averages | |
|---|---|
| Average Short Volume | 302,981 |
| Average Short Percentage | 13.96% |
Is there a CNCE Short Squeeze or Breakout about to happen?
See the CNCE Short Analysis for free Sign up or Login
Powered by Squeeze Report
CNCE Twenty Trading Day's Volume to Short Volume Chart
CNCE Twenty Trading Day Price Chart
CNCE Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 03-03-2023 | $8.38 | $8.37 | $8.55 | $8.35 | 10,733,298 | 1,365,891 | 12.73% |
| 03-02-2023 | $8.39 | $8.36 | $8.39 | $8.345 | 4,637,577 | 1,677,897 | 36.18% |
| 03-01-2023 | $8.37 | $8.39 | $8.39 | $8.37 | 2,169,805 | 156,577 | 7.22% |
| 02-28-2023 | $8.38 | $8.38 | $8.4 | $8.38 | 1,022,876 | 89,979 | 8.8% |
| 02-27-2023 | $8.39 | $8.4 | $8.41 | $8.38 | 1,701,244 | 202,137 | 11.88% |
| 02-24-2023 | $8.39 | $8.38 | $8.4 | $8.375 | 824,692 | 40,315 | 4.89% |
| 02-23-2023 | $8.39 | $8.39 | $8.405 | $8.39 | 1,337,003 | 116,387 | 8.71% |
| 02-22-2023 | $8.38 | $8.4 | $8.41 | $8.37 | 876,045 | 86,880 | 9.92% |
| 02-21-2023 | $8.38 | $8.35 | $8.41 | $8.34 | 1,846,216 | 164,040 | 8.89% |
| 02-17-2023 | $8.38 | $8.38 | $8.44 | $8.37 | 735,479 | 159,576 | 21.7% |
| 02-16-2023 | $8.35 | $8.38 | $8.41 | $8.345 | 1,561,765 | 208,026 | 13.32% |
| 02-15-2023 | $8.36 | $8.35 | $8.3862 | $8.33 | 1,187,358 | 179,413 | 15.11% |
| 02-14-2023 | $8.33 | $8.34 | $8.36 | $8.32 | 1,577,450 | 525,135 | 33.29% |
| 02-13-2023 | $8.33 | $8.325 | $8.37 | $8.32 | 754,410 | 138,195 | 18.32% |
| 02-10-2023 | $8.34 | $8.33 | $8.345 | $8.31 | 1,036,979 | 334,372 | 32.24% |
| 02-09-2023 | $8.38 | $8.33 | $8.39 | $8.31 | 1,718,143 | 95,314 | 5.55% |
| 02-08-2023 | $8.36 | $8.35 | $8.38 | $8.34 | 1,162,544 | 53,394 | 4.59% |
| 02-07-2023 | $8.38 | $8.36 | $8.41 | $8.35 | 2,136,917 | 207,927 | 9.73% |
| 02-06-2023 | $8.39 | $8.38 | $8.41 | $8.36 | 1,049,738 | 88,413 | 8.42% |
| 02-03-2023 | $8.38 | $8.37 | $8.4 | $8.35 | 2,229,743 | 169,754 | 7.61% |
News, Short Squeeze, Breakout and More Instantly...
Concert Pharmaceuticals Inc. Company Name:
CNCE Stock Symbol:
NASDAQ Market:
Concert Pharmaceuticals Inc. Website:
Ad
-
Concert Pharmaceuticals, Inc. today announced that, after a recent review of deuruxolitinib clinical data by the U.S. Food and Drug Administration (FDA), the FDA determined that deuruxolitinib will maintain its Breakthrough Therapy designation. Deuruxolitinib, an oral Janus kinase (JAK) inhibit...
-
If all goes according to plan, Concert Pharmaceuticals (NASDAQ: CNCE) will soon cease to be an independent company. The biotech signed a deal to be acquired by a peer; as a result, its share price leaped more than 17% higher on the week, according to data compiled by S&P Global Mark...
-
Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease Leverages Sun Pharma’s Global Infrastructure to Provide Broad Access to Deuruxolitinib for Patients with Alopecia Areata Strength...